Kristian Humer - Dec 31, 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
CFO and CBO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Kristian Humer
Stock symbol
VRDN
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 03:16 PM
Previous filing
Aug 2, 2021
Next filing
Feb 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +121K $0.00 121K Dec 31, 2021 Common Stock 121K $19.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.